Picture of Bioretec Oy logo

BRETEC Bioretec Oy News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Bioretec Expects FDA Approval For RemeOs Screws In April 2023

Oct 14 (Reuters) - Bioretec Oy  BRETEC.HE :
    * BIORETEC UPDATES ESTIMATE OF U.S. REGISTRATION OF REMEOS
SCREWS
AND EXPECTS APPROVAL IN APRIL 2023
    * PREVIOUSLY AUTHORIZATION WAS EXPECTED TO BE RECEIVED IN H2
2022
    * SHALL SUPPLEMENT AUTHORIZATION REQUEST IN ACCORDANCE WITH
DE
NOVO REGISTRATION PROCESS BY END OF 2022

Source text for Eikon:  ID:nWkr3BW1Dd 
Further company coverage:  BRETEC.HE 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

Recent news on Bioretec Oy

See all news